MarketCapExport financials
Crexendo (CXDO)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Crexendo Financial Ratios 2025-2009 | CXDO
Brief overview of Crexendo's multiples and efficiency
Ratios are assessed across five available annual reports in the 2019–2025 interval.
The latest available valuation ratios are P/E 157.91x (median 157.91x), P/S 2.82x (median 2.82x), P/B 3.01x (median 3.05x). The combined ratio level is close to the company's five-year norm at a -0.6% deviation. No clear premium or discount is visible.
At the current P/E, inverse earnings yield is 0.6%, a useful bridge between price and business earnings.
Capital efficiency is characterized by ROE 1.9%, ROA 1.6%, ROCE 1.8%. Low capital returns limit the ability to compound value internally.
The cash conversion cycle decreased 30.3 days to 24.8 days, supporting working-capital efficiency.
What the ratios show
Crexendo's profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios Crexendo
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157.9 | 313.5 | 2232.9 | -1.3 | -147683.1 | 13.4 | 60.1 | -144.6 | -43.0 | -6.9 | -2.1 | -2.9 | -6.6 | -7.5 | -7.4 | - | - | |
P/S |
2.8 | 2.6 | 2.6 | 3.8 | 9882.8 | 6.5 | 4.7 | 2.7 | 4.2 | 2.1 | 1.2 | 2.4 | 3.2 | 1.7 | 1.0 | - | - |
EPS |
0.0 | 0.0 | - | -1.3 | -0.0 | 0.5 | 0.1 | -0.0 | -0.1 | -0.2 | -0.3 | -0.6 | -0.5 | -0.4 | -0.6 | -0.2 | - |
EV (Enterprise Value) |
175 M | 154 M | 137 M | 52.3 M | 88.9 B | 94.1 M | 67.7 M | 32.9 M | 44.7 M | 21.8 M | 11.3 M | 18.5 M | 32.8 M | 29.5 M | 56.9 M | 17.3 M | -21.5 M |
EBITDA per Share |
0.05 | 0.03 | 0.02 | -1.49 | 0.01 | 0.0819 | 0.0843 | -0.00795 | -0.0516 | -0.196 | -0.353 | -0.532 | -0.405 | -0.446 | -0.429 | -0.46 | - |
EV/EBITDA |
129.6 | 166.1 | 310.9 | -1.5 | 379.6 | 72.9 | 52.3 | -267.1 | -59.4 | -7.6 | -1.9 | -2.6 | -6.9 | -4.7 | -8.2 | -3.3 | - |
PEG |
-0.05 | -0.1 | -0.68 | 0.0 | 523.94 | 0.02 | 0.12 | -2.02 | -0.65 | -0.17 | -0.05 | 0.12 | 0.27 | -0.2 | 0.04 | - | - |
P/B |
3.0 | 3.1 | 3.1 | 1.1 | 1348.4 | 4.1 | 15.6 | 16.1 | 32.8 | 37.6 | 4.2 | 4.1 | 4.9 | 2.9 | 3.4 | - | - |
P/CF |
20.7 | 25.3 | 38.9 | -106.0 | -88375.0 | -389.5 | 43.7 | 72.5 | 149.3 | -17.2 | -3.1 | -4.2 | -6.1 | -18.4 | -14.7 | - | - |
ROE % |
1.91 | 0.99 | 0.14 | -78.63 | -0.91 | 30.82 | 25.96 | -11.15 | -76.18 | -542.14 | -206.03 | -140.32 | -74.06 | -38.29 | -46.68 | -11.48 | - |
ROA % |
1.57 | 0.78 | 0.11 | -58.60 | -0.78 | 25.86 | 14.63 | -4.90 | -29.60 | -79.03 | -80.23 | -84.85 | -51.66 | -22.49 | -18.84 | -4.47 | - |
ROCE % |
1.73 | 1.18 | 0.08 | -76.48 | -1.20 | 3.52 | 23.18 | -8.12 | -59.78 | -179.42 | -144.06 | -137.16 | -80.39 | -55.88 | -29.62 | -21.22 | - |
Current Ratio |
5.6 | 4.8 | 4.9 | 3.9 | 6.9 | 7.7 | 2.0 | 1.7 | 1.2 | 1.0 | 1.4 | 1.8 | 2.0 | 2.0 | 1.6 | 1.6 | - |
DSO |
24.8 | 23.5 | 23.2 | 87.3 | 55.1 | 22.0 | 13.9 | 15.3 | 17.3 | 18.7 | 23.1 | 34.3 | 43.8 | 74.5 | 75.8 | - | - |
DIO |
- | - | - | - | - | 37.2 | 32.0 | 25.8 | 13.8 | 17.1 | 13.7 | 7.3 | 19.4 | 12.3 | 4.8 | - | - |
DPO |
- | - | - | - | - | 41.4 | 54.7 | 38.0 | 8.3 | 11.7 | 7.8 | 4.8 | 17.9 | 30.0 | 23.7 | 27.9 | - |
Operating Cycle |
- | - | - | - | - | 59.2 | 45.9 | 41.1 | 31.1 | 35.8 | 36.8 | 41.7 | 63.1 | 86.8 | 80.6 | - | - |
Cash Conversion Cycle |
- | - | - | - | - | 17.8 | -8.8 | 3.1 | 22.8 | 24.1 | 29.0 | 36.9 | 45.2 | 56.8 | 56.8 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Crexendo
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.03 | 0.03 | 0.02 | 0.04 | 0.05 | 0.04 | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | - | 0.07 | -0.02 | -0.06 | -1.33 | -0.03 | -0.04 | -0.05 | -0.03 | -0.01 | -0.05 | -0.04 | 0.4 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | - | -0.01 | - | - | - | -0.01 | -0.02 | -0.04 | -0.04 | -0.05 | -0.06 | -0.07 | -0.1 | -0.08 | -0.08 | -0.09 | -0.15 | -0.13 | -0.13 | -0.15 | -0.17 | -0.13 | -0.13 | -0.15 | -0.3 | -0.08 | -0.01 | 0.02 | 0.04 | 0.43 | -0.88 | -0.17 |
EBITDA per Share |
0.09 | 0.09 | 0.05 | 4.93 | 0.07 | 0.06 | 0.07 | 9.39 | 0.03 | 0.02 | 0.05 | -0.02 | 0.02 | -0.02 | -0.03 | -67.4 | -0.02 | -0.03 | -0.03 | -0.04 | 0.01 | 0.07 | 0.05 | -0.01 | 0.01 | 0.03 | 0.01 | 3.69 | 0.02 | 0.02 | 0.02 | - | -0.01 | 0.01 | - | 0.18 | - | -0.01 | -0.03 | -9.64 | -0.04 | -0.06 | -0.07 | -13.1 | -0.08 | -0.08 | -0.11 | -2.96 K | -0.13 | -0.13 | 16.1 | -62.7 | -0.14 | -0.09 | -0.05 | -0.22 | -0.09 | -0.02 | -0.03 | 9.15 | 0.34 | -0.39 | -0.36 |
ROE % |
5.45 | 6.41 | 7.18 | 8.51 | 7.58 | 5.52 | 4.63 | 3.43 | 2.58 | 6.19 | 3.64 | -1.16 | -79.93 | -84.88 | -84.91 | -79.19 | -1.47 | -0.61 | -0.79 | 0.04 | 28.75 | 29.75 | 40.08 | 40.37 | 17.77 | 26.11 | 28.45 | 35.74 | 30.14 | 10.60 | 2.04 | -12.08 | -9.71 | -14.74 | 38.81 | -58.90 | -134.29 | -208.48 | -332.80 | -286.54 | -270.65 | -217.84 | -178.89 | -154.48 | -135.42 | -137.80 | -137.60 | -132.83 | -121.76 | -102.67 | -84.20 | -61.98 | -65.82 | -51.79 | -42.05 | -36.71 | -2.03 | 39.06 | -65.94 | -77.54 | 35.03 | -105.82 | -10.19 |
ROA % |
4.32 | 5.15 | 5.84 | 6.94 | 6.15 | 4.48 | 3.74 | 2.76 | 2.09 | 4.93 | 2.94 | -0.77 | -59.47 | -63.47 | -63.64 | -59.09 | -1.27 | -0.52 | -0.62 | -0.07 | 24.04 | 24.79 | 30.44 | 29.71 | 9.31 | 13.25 | 13.99 | 16.48 | 13.37 | 4.39 | 0.40 | -5.20 | -4.17 | -5.30 | 18.07 | 5.54 | -10.17 | -18.66 | -59.07 | -61.52 | -69.06 | -73.18 | -74.55 | -75.97 | -76.83 | -80.27 | -81.46 | -81.56 | -77.40 | -71.02 | -60.80 | -45.50 | -44.73 | -33.34 | -25.52 | -21.98 | -2.25 | 14.03 | -6.96 | -11.28 | 12.42 | -21.44 | -3.65 |
ROCE % |
4.84 | 5.67 | 6.28 | 7.73 | 7.18 | 5.35 | 4.67 | 3.64 | 2.54 | 3.08 | 0.73 | -3.81 | -80.38 | -81.98 | -82.10 | -80.66 | -5.37 | -4.50 | -1.40 | 3.53 | 5.17 | 5.92 | 10.58 | 10.28 | 14.29 | 20.41 | 21.83 | 25.81 | 13.47 | 8.63 | -2.38 | -8.90 | -7.86 | -4.10 | -19.71 | -48.50 | -78.80 | -109.45 | -130.66 | -131.24 | -141.49 | -141.11 | -134.39 | -136.07 | -134.13 | -137.21 | -137.70 | -128.86 | -119.87 | -103.12 | -86.49 | -69.31 | -73.26 | -61.02 | -53.02 | -49.01 | -19.48 | 4.58 | -12.60 | -22.07 | 15.56 | -21.02 | -13.61 |
Current Ratio |
4.4 | 4.4 | 4.9 | 5.6 | 5.2 | 5.5 | 5.5 | 4.8 | 4.9 | 5.2 | 5.4 | 4.9 | 4.8 | 4.2 | 4.2 | 3.9 | 7.5 | 7.6 | 7.4 | 6.9 | 6.7 | 6.0 | 5.1 | 6.2 | 3.7 | 2.0 | 1.9 | 2.3 | 2.0 | 1.9 | 1.6 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.6 | 1.8 | 1.2 | 1.2 | 1.2 | 1.3 | 1.4 | 1.6 | 2.0 | 2.5 | 2.4 | 2.5 | 2.2 | 2.8 | 3.3 | 3.3 | 4.2 | 3.9 | 3.7 | 2.4 | 2.8 | 2.2 | 1.9 | 1.7 | 1.6 | 1.2 | 1.6 |
DSO |
22.1 | 23.2 | 24.9 | 24.4 | 27.0 | 26.7 | 23.9 | 22.8 | 22.6 | 25.5 | 24.6 | 23.7 | 24.4 | 26.4 | 25.9 | 29.2 | 37.8 | 32.1 | 27.3 | 17.5 | 13.9 | 14.9 | 10.4 | 12.3 | 13.2 | 11.3 | 9.6 | 10.0 | 12.1 | 13.9 | 13.1 | 11.5 | 11.2 | 11.4 | 11.9 | 12.3 | 13.6 | 15.0 | 14.8 | 12.6 | 14.2 | 18.5 | 18.1 | 16.6 | 17.4 | 19.4 | 24.7 | 27.4 | 34.5 | 35.4 | 40.5 | 47.3 | 46.5 | 54.6 | 75.2 | 107.3 | 142.4 | 155.5 | 160.0 | 199.0 | 138.2 | 65.0 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.5 | - | - | - | 29.8 | 24.7 | - | - | 34.3 | 34.0 | - | - | - | - | - | - | - | - | - | - | - | - | 26.4 | 15.5 | 12.4 | 12.8 | 13.1 | 11.6 | 10.0 | 6.8 | 6.4 | 5.9 | 9.8 | 13.5 | 17.8 | 16.2 | 12.3 | 11.5 | 12.5 | 14.2 | 14.4 | 16.4 | 15.9 | 17.6 | 20.3 | 9.1 | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.7 | - | - | - | 48.1 | 28.5 | - | - | 16.7 | 9.3 | - | - | - | - | - | - | - | - | - | - | - | - | 16.4 | 22.4 | 27.9 | 21.6 | 12.4 | 17.3 | 20.2 | 14.2 | 11.6 | 10.3 | 11.6 | 5.5 | 13.8 | 12.6 | 17.1 | 28.6 | 31.5 | 42.3 | 40.7 | 53.5 | 71.0 | 55.0 | 45.2 | 13.7 | - |
Operating Cycle |
22.1 | 23.2 | 24.9 | 24.4 | 27.0 | 26.7 | 23.9 | 22.8 | 22.6 | 25.5 | 24.6 | 23.7 | 24.4 | 26.4 | 25.9 | 29.2 | 52.3 | 32.1 | 27.3 | 17.5 | 43.7 | 39.7 | 10.4 | 12.3 | 47.5 | 45.3 | 9.6 | 10.0 | 12.1 | 13.9 | 13.1 | 11.5 | 11.2 | 11.4 | 11.9 | 12.3 | 13.6 | 15.1 | 41.2 | 28.2 | 26.6 | 31.4 | 31.2 | 28.2 | 27.4 | 26.3 | 31.1 | 33.3 | 44.2 | 48.8 | 58.3 | 63.5 | 58.7 | 66.2 | 87.7 | 121.6 | 156.8 | 171.9 | 175.9 | 216.6 | 158.6 | 74.2 | - |
Cash Conversion Cycle |
22.1 | 23.2 | 24.9 | 24.4 | 27.0 | 26.7 | 23.9 | 22.8 | 22.6 | 25.5 | 24.6 | 23.7 | 24.4 | 26.4 | 25.9 | 29.2 | 25.6 | 32.1 | 27.3 | 17.5 | -4.4 | 11.2 | 10.4 | 12.3 | 30.8 | 36.0 | 9.6 | 10.0 | 12.1 | 13.9 | 13.1 | 11.5 | 11.2 | 11.4 | 11.9 | 12.3 | 13.6 | 15.1 | 24.8 | 5.8 | -1.4 | 9.7 | 18.9 | 10.9 | 7.2 | 12.0 | 19.5 | 23.0 | 32.6 | 43.3 | 44.5 | 50.9 | 41.6 | 37.5 | 56.1 | 79.3 | 116.0 | 118.4 | 104.9 | 161.6 | 113.3 | 60.4 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Crexendo, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
China
India
Irlanda
Canada
Bermuda
